학술논문
Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis
Document Type
Article
Author
Source
In Annals of Oncology February 2014 25(2):529-536
Subject
Language
ISSN
0923-7534